Lupin's Nagpur facility gets US FDA VAI classification

Lupin is a company that makes medicines.

They have a factory in Nagpur, India, where they make injections.

The US FDA, which is like a big boss for medicines in the US, checked this factory from September 8 to September 16, 2025.

After checking, they gave the factory a special approval called VAI classification.

This means the factory is good and follows all the rules.

On the day this news came out, Lupin's stock price was ₹2,085.90, which was a little less than the day before.